Ximeceff 200 Tablet DT contains Cefixime 200 mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. This formulation is designed as a dispersible tablet, facilitating ease of administration, especially in patients with swallowing difficulties. Ximeceff 200 is indicated for the treatment of infections caused by susceptible strains of microorganisms, including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, otitis media, pharyngitis, and gonorrhea. The drug exhibits activity against both gram-positive and gram-negative bacteria, including Escherichia coli, Haemophilus influenzae, and Streptococcus pneumoniae. Dosage should be individualized based on the severity of infection, patient age, and renal function, with the usual adult dose being 200 mg twice daily. The dispersible tablet should be dissolved in a small amount of water prior to administration. Cefixime is generally well tolerated; however, adverse reactions may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Hypersensitivity reactions, including rash and anaphylaxis, though rare, require immediate medical attention. Use of Ximeceff 200 should be guided by susceptibility testing to minimize the development of resistance.